196 related articles for article (PubMed ID: 6139019)
1. Pharmacologic and physiologic considerations of adrenoceptor blockade.
Frohlich ED; Dunn FG; Messerli FH
Am J Med; 1983 Oct; 75(4A):9-14. PubMed ID: 6139019
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
Koch G
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
5. The hemodynamic effects of adrenergic blocking agents.
Lund-Johansen P
Cleve Clin J Med; 1992; 59(2):193-200. PubMed ID: 1350235
[TBL] [Abstract][Full Text] [Related]
6. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
[TBL] [Abstract][Full Text] [Related]
7. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
Koch G
Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
Koch G; Fransson L
Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive mechanisms of beta blockers.
Conway J
Eur Heart J; 1983 Jul; 4 Suppl D():43-51. PubMed ID: 6137382
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog.
Saito D; Abe Y; Tani H; Kusachi S; Takeda K; Hyodo T; Haraoka S; Nagashima H
Arzneimittelforschung; 1986; 36(1):88-91. PubMed ID: 2869764
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
Lund-Johansen P; Omvik P
Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
[TBL] [Abstract][Full Text] [Related]
13. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
Erkinaro T; Kavasmaa T; Ylikauma L; Mäkikallio K; Haapsamo M; Acharya G; Ohtonen P; Alahuhta S; Räsänen J
Reprod Sci; 2009 Aug; 16(8):749-57. PubMed ID: 19380903
[TBL] [Abstract][Full Text] [Related]
14. Comparison of labetalol with other anti-hypertensive drugs.
Prichard BN; Richards DA
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
16. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
MacCarthy EP; Bloomfield SS
Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529
[TBL] [Abstract][Full Text] [Related]
17. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.
Bakris G
J Cardiovasc Pharmacol; 2009 May; 53(5):379-87. PubMed ID: 19454898
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of antihypertensive drugs.
Itskovitz HD
Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
[TBL] [Abstract][Full Text] [Related]
20. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
